Quantcast
Last updated on April 23, 2014 at 21:24 EDT

Latest Roskamp Institute Stories

2012-04-26 06:25:20

GLEN ALLEN, Va., April 26, 2012 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: CIGX) through its wholly owned subsidiary, Rock Creek Pharmaceuticals, Inc., announces that it has received IRB approval of the first human clinical study of the safety and effects of nutritional supplementation with Anatabloc® in individuals with Alzheimer's disease. The study will be undertaken in conjunction with the Roskamp Institute of Sarasota, Florida, which has been acting as a research partner in...

2012-02-15 06:41:44

(Ivanhoe Newswire) -- From stress to insomnia to anxiety, whatever the cause may be, new research shows that lack of sleep at night could affect memory later in life. “Disrupted sleep appears to be associated with the build-up of amyloid plaques, a hallmark marker of Alzheimer´s disease, in the brains of people without memory problems. Further research is needed to determine why this is happening and whether sleep changes may predict cognitive decline,” the study author at...

Sleep Problems Could Affect Your Memory
2012-02-15 04:59:40

The amount and quality of sleep you get at night may affect your memory later in life, according to research that was released this week and will be presented at the American Academy of Neurology's 64th Annual Meeting in New Orleans April 21 to April 28, 2012. "Disrupted sleep appears to be associated with the build-up of amyloid plaques, a hallmark marker of Alzheimer's disease, in the brains of people without memory problems," said study author Yo-El Ju, MD, with Washington University...

2012-01-11 09:54:00

GLEN ALLEN, Va., Jan. 11, 2012 /PRNewswire/ -- Star Scientific, Inc. (NASDAQ: CIGX) - A study released in the January 9th issue of the Journal of Neurology suggests that nicotine patches may help individuals with early memory loss. Dr. Paul Newhouse, a professor of psychiatry at Vanderbilt University Medical Center, led a study which showed that six months of nicotine patch treatment among patients who had mild cognitive impairment - often a precursor to Alzheimer's disease - had a...

2011-10-04 13:35:00

GLEN ALLEN, Va., Oct. 4, 2011 /PRNewswire/ -- Star Scientific, Inc. (Nasdaq: CIGX) reports today the publication of the first peer-reviewed article on the in-vitro and in-vivo activity of anatabine in Alzheimer's Disease. The article is authored by scientists at the Roskamp Institute and is electronically published in the European Journal of Pharmacology (2011 Sept 19). It states that anatabine lowers Alzheimer's A-beta production in-vitro and in-vivo. (Logo:...

2011-03-04 12:46:00

LA JOLLA, Calif., March 4, 2011 /PRNewswire/ -- Unexpected results from a Scripps Research Institute and ModGene, LLC study could completely alter scientists' ideas about Alzheimer's disease -- pointing to the liver instead of the brain as the source of the "amyloid" that deposits as brain plaques associated with this devastating condition. The findings could offer a relatively simple approach for Alzheimer's prevention and treatment. The study was published online in The Journal of...

2011-02-28 08:30:00

GLEN ALLEN, Va., Feb. 28, 2011 /PRNewswire/ -- Rock Creek Pharmaceuticals, a wholly owned subsidiary of Star Scientific, Inc. (Nasdaq: CIGX) has been notified by the Roskamp Institute of Sarasota, Florida that the Institute has received institutional review board (IRB) approval to conduct a three-month, multi-site clinical trial with Rock Creek's RCP-006 nutritional supplement formula. The study (referred to as the "Flint Study"), will enroll approximately 200 subjects and begins with...

2010-11-10 08:30:00

GLEN ALLEN, Va., Nov. 10, 2010 /PRNewswire-FirstCall/ -- Star Scientific, Inc. (Nasdaq: CIGX) filed the company's third-quarter financial report yesterday with the Securities & Exchange Commission. The company reported $695 thousand in net sales for the nine months ended September 30, 2010 compared with $618 thousand for the same period in 2009. Net sales for the third quarter totaled $211 thousand compared with $232 thousand for third-quarter 2009. The decrease in third-quarter 2010...

2010-10-07 10:39:00

GLEN ALLEN, Va., Oct. 7 /PRNewswire-FirstCall/ -- Star Scientific, Inc. (Nasdaq: CIGX) has issued the following comment by Paul L. Perito, Rock Creek Pharmaceuticals' Chairman and CEO: (Logo: http://www.newscom.com/cgi-bin/prnh/20090317/STARSCIENTIFICLOGO ) (Logo: http://photos.prnewswire.com/prnh/20090317/STARSCIENTIFICLOGO ) "We are gratified that the Roskamp Institute, a highly credentialed scientific foundation, has made a significant medical discovery that we believe holds the...

2010-10-07 09:25:00

SARASOTA, Fla., Oct. 7 /PRNewswire-USNewswire/ -- Today the Roskamp Institute said that it is pleased to announce that it will soon begin clinical trials of RCP-006, a compound found in tobacco, for the treatment of Alzheimer's disease. The compound was developed by Rock Creek Pharmaceuticals, a subsidiary of Star Scientific in Virginia, and made available to Roskamp through its affiliate, SRQ Bio, LLC. In laboratory tests with cells, the compound, RCP-006, a natural product, inhibits...